Investigational Drug Information for Volinanserin
✉ Email this page to a colleague
What is the development status for investigational drug Volinanserin?
Volinanserin is an investigational drug.
There have been 4 clinical trials for Volinanserin.
The most recent clinical trial was a Phase 3 trial, which was initiated on April 1st 2007.
The most common disease conditions in clinical trials are Sleep Initiation and Maintenance Disorders, Diabetes Mellitus, Type 2, and Diabetes Mellitus. The leading clinical trial sponsors are Sanofi and [disabled in preview].
Summary for Volinanserin
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 404 |
| WIPO Patent Applications | 264 |
| Japanese Patent Applications | 135 |
| Clinical Trial Progress | Phase 3 (2007-04-01) |
| Vendors | 61 |
Recent Clinical Trials for Volinanserin
| Title | Sponsor | Phase |
|---|---|---|
| Comparison of Volinanserin and Lormetazepam in the Treatment of Insomnia Characterized by Sleep Maintenance Difficulties | Sanofi | Phase 3 |
| Efficacy and Safety of M100907 on Sleep Maintenance Insomnia With a Sub-study in Stable Type II Diabetes Mellitus | Sanofi | Phase 3 |
| Efficacy an Safety of Volinanserin on Sleep Maintenance Insomnia With a Sub-study on Stable Type II Diabetes Mellitus | Sanofi | Phase 3 |
Clinical Trial Summary for Volinanserin
Top disease conditions for Volinanserin
Top clinical trial sponsors for Volinanserin
US Patents for Volinanserin
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
